Significant Customer and Geographic Information (Tables)

12 Months Ended

Dec. 31, 2017

Segment Reporting Information, Operating Income (Loss) [Abstract]

Customers that each contributed 10% or more of our total revenues were as follows:



	Percentage of Total Revenues For The Years Ended December 31,
	2017		2016		2015
Merck	28	%	47	%	29	%
GSK	*		22	%	20	%
Novartis	14	%	*		*
Nestlé	15	%	*		*
Exela	*		*		12	%
Tate & Lyle	11	%	*		*

Customers that each accounted for 10% or more of our accounts receivable balance for the period presented were as follows:



	Percentage of Accounts Receivables As Of December 31,
	2017		2016
Merck	31	%	54	%
Pfizer	*		16	%
Exela	14	%	*
Tate & Lyle	16	%	*
Novartis	15	%	*

* Percentage was less than 10%

Schedule of revenues by geographical area

Geographic revenues are identified by the location of the customer and consist of the following (in thousands):



	Years Ended December 31,
	2017		2016		2015
Revenues
United States	$	15,469	$	21,310	$	23,293
India	5,639		3,578		1,026
Singapore	6,165		3,836		963
United Kingdom	51		10,851		8,721
Switzerland	13,216		2,315		1,574
Rest of world ⁽²⁾	9,484		6,947		6,227
Total revenues	$	50,024	$	48,837	$	41,804

⁽²⁾ No other country accounted for at least 10% of total revenue for the years above.

Schedule of long-lived assets by geographical area

Geographic presentation of identifiable long-lived assets below shows those assets that can be directly associated with a particular geographic area and consist of the following (in thousands):



	December 31,
	2017		2016
Long-lived assets
United States	$	3,117	$	2,414